Biotecnología

Biotecnología

Events - EAPM Croatia Presidency Conference “Defining the healthcare ecosystem to determine value” - 24 March 2020, Brussels, Belgium
19/02/2020 - The European Alliance for Personalised Medicine is delighted to announce the first of three EU Presidency-themed conferences for 2020. These will be, firstly, during the Croatia Presidency,...
FDA informs health care providers, facilities and patients about potential cybersecurity vulnerabilities for certain GE Healthcare Clinical Information Central Stations and Telemetry Servers
19/02/2020 - FDA is issuing a safety communication informing health care providers, facilities and patients about cybersecurity vulnerabilities identified for certain GE Healthcare Clinical Information Central...
Events - HBP Curriculum Workshop: Measuring and modelling brain states - 28-29 March 2020, Sölden, Austria
19/02/2020 - The final workshop of the 3rd HBP Curriculum Workshops Series invites researchers interested in measuring and modelling brain states at multiple scales. At the cellular level, the appearance of...
FDA approves first treatment for thyroid eye disease
19/02/2020 - FDA approved Tepezza for the treatment of adults with thyroid eye disease. Today’s approval represents the first drug approved for the treatment of thyroid eye disease.
Events - RE(ACT) congress – IRDiRC conference - 11-14 March 2020, Berlin, Germany
19/02/2020 - Join a major event on rare diseases in 2020: The RE(ACT) Congress and IRDiRC Conference, 11-14 March 2020, Meliá Berlin Hotel, Berlin. Young and professional scientists, patients &...
Statement on quality issues with certain Cardinal Health surgical gowns and packs
19/02/2020 - Statement from Jeff Shuren, M.D., J.D., director of FDA’s Center for Devices and Radiological Health on quality issues with certain Cardinal Health surgical gowns and packs
Colorado unapproved drug and dietary supplement makers ordered to cease operations for federal violations
19/02/2020 - Yesterday, U.S. District Judge Marcia S. Krieger for the U.S. District Court for Colorado entered a consent decree of permanent injunction against EonNutra LLC, CDSM LLC and HABW LLC, manufacturers...
Statement on the Salinas-linked romaine lettuce E. coli O157:H7 outbreak and status update on investigation
19/02/2020 - Romaine outbreaks declared over, investigation advances, root cause analysis continues
FDA Takes Action with Indian Government to Protect Consumers From Illicit Medical Products
19/02/2020 - The FDA announced that in partnership with the Government of India, approximately 500 shipments of illicit and potentially dangerous, unapproved prescription drugs and combination medical devices...
Michigan-based food manufacturer agrees to stop production after repeated food safety violations
19/02/2020 - Home Style Foods, Inc., a Michigan-based food manufacturer, has agreed to discontinue selling food products until the company complies with federal regulations and other requirements.
FDA Approves Three Drugs for Nonprescription Use Through Rx-to-OTC Switch Process
19/02/2020 - FDA Approves Three Drugs for Nonprescription Use Through Rx-to-OTC Switch Process
FDA approves first generics of Eliquis
19/02/2020 - The U.S. Food and Drug Administration today approved two applications for first generics of Eliquis (apixaban) tablets.
FDA’s Actions in Response to 2019 Novel Coronavirus at Home and Abroad
19/02/2020 - FDA is an active partner in the COVID-19 response, working closely with government and public health partners across HHS and international counterparts.
Statement from FDA Commissioner Scott Gottlieb, M.D., in response to GAO report regarding FDA’s ongoing commitment to employing a least burdensome approach to device review
19/02/2020 - Statement from FDA Commissioner Scott Gottlieb, M.D., in response to GAO report regarding FDA’s ongoing commitment to employing a least burdensome approach to device review
FDA Expertise Advancing the Understanding of Intentional Genomic Alterations in Animals
19/02/2020 - FDA analysis published today advances the understanding of intentional genomic alterations in animals.
FDA Authorizes Marketing of First Cardiac Ultrasound Software That Uses Artificial Intelligence to Guide User
19/02/2020 - Today, the U.S. Food and Drug Administration authorized marketing of software to assist medical professionals in the acquisition of cardiac ultrasound, or echocardiography, images.
FDA Takes Significant Step in Coronavirus Response Efforts, Issues Emergency Use Authorization for the First 2019 Novel Coronavirus Diagnostic
19/02/2020 - Today, FDA issued an EUA to enable emergency use of CDC’s 2019-nCoV Real-Time RT-PCR Diagnostic Panel. To date, this test has been limited to use at CDC laboratories; today’s authorization...
FDA Announces Key Actions to Advance Development of Novel Coronavirus Medical Countermeasures
19/02/2020 - FDA Announces Key Actions to Advance Development of Novel Coronavirus Medical Countermeasures
FDA approves first drug for treatment of peanut allergy for children
19/02/2020 - FDA approves first drug for treatment of peanut allergy for childrenTreatment with this product may be initiated in individuals ages 4 through 17 years with a confirmed diagnosis of peanut...
FDA and FTC Announce New Efforts to Further Deter Anti-Competitive Business Practices, Support Competitive Market for Biological Products to Help Americans
19/02/2020 - The U.S. Food and Drug Administration and the Federal Trade Commission signed a joint statement regarding enhanced collaboration in support of a robust marketplace for biological products.
FDA launches mobile-friendly database with information on life-saving HIV drugs as part of ongoing mission to empower the public through increased access to information and data
19/02/2020 - FDA launches an interactive database that will offer a wealth of critical information about antiretrovirals (ARVs) eligible for purchase under the President’s Emergency Plan for AIDS Relief...